Advances in Managing Neuropsychiatric Symptoms of Alzheimer’s Disease: From Early Detection to Emerging Therapies
Marwan Sabbagh, MD, FAAN
Christoph U. Correll, MD
Alireza Atri, MD, PhD
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
Treatment of a Broader Population of Patients With DMD
Crystal Proud, MD
Erika Finanger, MD, MS
Recognizing Early Signs of LGMD2I/R9
John Vissing, MD, DMSci
The Role of Multidisciplinary Care in LGMD2I/R9
Conrad Weihl, MD, PhD
Bridging Gaps in LGMD Care
Establishing Our Foundation of LGMD2I/R9: Unlocking the Genetics
Advancing Care: Clinical Innovations on the Horizon
Optimizing Patient Management Strategies
Navigating the LGMD2I/R9 Diagnostic Pathway
Establishing Our Foundation of LGMD2I/R9
Integrating Perspectives: The Value of Patient and Caregiver Input
The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?
Alejandro A. Rabinstein, MD, FAHA
Richard E. Pratley, MD
Jay H. Shubrook, DO, FACOFP, FAAFP
New Frontiers in the Treatment of DMD Across the Age Spectrum
John Brandsema, MD
Omer Abdul Hamid, MD
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
James R. Bateman, MD, MPH
Charles P. Vega, MD
B. Joy Snider, MD, PhD
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.